Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Scope of Global Antidiabetic Drug Sales Market in Conjunction with the Future Potential of This Market in All Regions

The report covers the present scenario and the growth prospects of the Global Antidiabetic Drug Sales Market for 2018-2025. To calculate the market size, the report considers the in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

This press release was orginally distributed by SBWire

City of Industry, CA -- (SBWIRE) -- 06/15/2018 -- This report studies the global Antidiabetic Drug market status and forecast, categorizes the global Antidiabetic Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and ? cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug

The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/479293/global-antidiabetic-drug-sales-market

Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.

The global Antidiabetic Drug market is valued at 49600 million US$ in 2017 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.

The major players covered in this report

Sanofi-Aventis

Eli Lilly

Oramed

Takeda

Boehringer Ingelheim

Novo Nordisk

Halozyme Therapeutics

Bristol-Myers Squibb

Pfizer

Tonghua Dongbao

Biocon

Wockhardt

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/479293/global-antidiabetic-drug-sales-market

For more information on this press release visit: http://www.sbwire.com/press-releases/scope-of-global-antidiabetic-drug-sales-market-in-conjunction-with-the-future-potential-of-this-market-in-all-regions-995939.htm

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, INC.
Telephone: 626-295-2442
Email: Click to Email Rahul Singh
Web: https://www.qyresearch.com/index/detail/479293/global-antidiabetic-drug-sales-market